Flexible Payment Plan
How it Works
No credit check required, $0 down, and monthly payments as low as $50 per month — up to 48 months.*
Who is Eligible
Any potential pump user who purchases their insulin pump directly through Tandem Diabetes Care using a DME benefit.
Note: For anyone fulfilling pump orders with distributor partners using a DME benefit, please inquire about payment plans directly with the distributor.
Not Eligible
This program excludes potential pump users using Medicare, Medicaid, Tricare, or any other federal state health programs, users who are residents of the state of Florida, users who are members of certain health plans or insurance contracts that prohibit this program, and users who are using a pharmacy benefit.
Take the First StepGet a Tandem Pump
Whether you're ready to get an insulin pump, or looking to check insurance coverage, you'll find everything you need here.
Frequently Asked Questions
* Monthly payment includes a $6.50/month processing fee. Subject to program eligibility requirements. Final cost may vary depending on individual insurance and individual payment timeline.
Program Terms and Conditions
Program terms and conditions are subject to change at any time, without notice. Tandem may discontinue enrollment in this program in its discretion at any time. Program offered only for t:slim X2 or Tandem Mobi insulin pumps purchased directly from Tandem Diabetes Care, Inc. after September 19, 2022. Program may not be available in all states.
The following customers are not eligible to participate in the flexible payment plan: 1. members of Medicare, Medicaid, Tricare, or any other federal or state health program (such as medical assistance programs); 2. residents of the state of Florida; 3. members of health plans specifically prohibiting payment plans and 4. customers obtaining the pump through a pharmacy benefit.
The minimum monthly payment is $50 per month. The monthly payment includes a $6.50 per month processing fee. The number of payments in an applicable payment plan may vary, but payment plan may not exceed 48 months. Final cost may vary depending on individual insurance coverage and individual payment plan duration. There is no early payment or early payoff penalty. Monthly payments do not include infusion sets or cartridges except for the initial supply of infusion sets and cartridges approved by insurance at the time of pump purchase. Customers must purchase additional infusion sets and pump cartridges separately to continue using pump therapy.
The t:slim X2 insulin pump with Control-IQ technology have certain labeling restrictions that may exclude certain populations, including age and type of diabetes. Consult your healthcare provider for more information. A valid prescription is required. Other restrictions or conditions may apply.
Important Safety Information
RX ONLY.
Indications for Use
Tandem Mobi system: The Tandem Mobi insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The Pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater.
t:slim X2 insulin pump: The t:slim X2 insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is indicated for use in persons 2 years of age and greater.
Control-IQ+ technology: Control-IQ+ technology is intended for use with compatible integrated continuous glucose monitors (iCGM, sold separately) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ+ technology is intended for the management of type 1 diabetes mellitus in persons 2 years of age and greater and of type 2 diabetes mellitus in persons 18 years of age and greater.
Warning: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds (9 kilograms), as those are the required minimum values needed for Control-IQ+ to operate safely.
Users of the pump and Control-IQ+ must: use the insulin pump, iCGM, and all other system components in accordance with their respective instructions for use. Failure to follow these instructions for use could result in an over delivery or under delivery of insulin. This can cause hypoglycemia (low BG) or hyperglycemia (high BG) events. Visit tandemdiabetes.com/safetyinfo for additional important safety information.